Trial intelligence / Profile preview

Sanwei joint plaster for early- to mid-stage knee osteoarthritis with qi stagnation and blood stasis

ChiCTR2400083731Phase 2Recruiting

Sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Start
Apr 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of sanwei joint plaster and celecoxib in knee osteoarthritis (OA) (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Visual Analog Scale pain score, Duration of pain relief and 2 more. Started Apr 2024; status: recruiting.

02

Drugs

sanwei joint plastercelecoxib
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2400083731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400083731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call